Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
---|---|---|---|---|---|---|---|
LAIDLAW & COMPANY (UK) LTD. | 119037 | MEI Pharma, Inc. | 1262104 | 05/30/2018 | D | $74,999,990 | $74,999,990 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | FUSION TELECOMMUNICATIONS INTERNATIONAL INC | 1071411 | 01/09/2014 | D | $24,000,000 | $18,480,000 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | CutWater Capital Partners, LLC | 1853457 | 04/13/2021 | D | $25,000,000 | $15,727,050 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | Relmada Therapeutics, Inc. | 1554535 | 05/22/2014 | D | $15,051,110 | $15,051,110 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | CatchWater Capital, LLC | 1867902 | 06/22/2021 | D | $25,000,000 | $12,125,000 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | MABVAX THERAPEUTICS HOLDINGS, INC. | 1109196 | 04/09/2015 | D | $15,000,000 | $11,614,501 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | Pershing Gold Corp. | 1432196 | 04/23/2015 | D | $15,000,000 | $11,480,326 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | Face-Off Partners, LLC | 1491789 | 05/12/2010 | D | $12,000,000 | $11,295,417 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | U.S. Gold Corp. | 1685963 | 09/29/2016 | D | $12,000,000 | $11,000,000 |
LAIDLAW & COMPANY (UK) LTD. | 119037 | ViralClear Pharmaceuticals, Inc. | 1783807 | 06/03/2020 | D | $25,000,000 | $10,751,250 |